PET imaging in glioma: techniques and current evidence
PET holds potential to provide additional information about tumour metabolic processes, which could aid brain tumour differential diagnosis, grading, molecular subtyping and/or the distinction of therapy effects from disease recurrence. This review discusses PET techniques currently in use for untre...
Gespeichert in:
| Veröffentlicht in: | Nuclear medicine communications 2018-12, Vol.39 (12), p.1064-1080 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1080 |
|---|---|
| container_issue | 12 |
| container_start_page | 1064 |
| container_title | Nuclear medicine communications |
| container_volume | 39 |
| creator | Mansoor, Nina M Thust, Stefanie Militano, Vincenzo Fraioli, Francesco |
| description | PET holds potential to provide additional information about tumour metabolic processes, which could aid brain tumour differential diagnosis, grading, molecular subtyping and/or the distinction of therapy effects from disease recurrence. This review discusses PET techniques currently in use for untreated and treated glioma characterization and aims to critically assess the evidence for different tracers ([F]Fluorodeoxyglucose, choline and amino acid tracers) in this context. |
| doi_str_mv | 10.1097/MNM.0000000000000914 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2118310422</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2118310422</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3054-b82668e0baf3e456cea83cf5522fb4355b9c22419ed2657e348bbed64cc99fde3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwBwhlySbF7zjsUFUeUgssytpynEkbSJxiJ1T8PalaEGLBzGI2596ZuQidEzwmOE2u5o_zMf5dKeEHaEh4wmIhqTpEQ0w4i5lkcoBOQnjtGcVkcowGDPetJB4i-TxdRGVtlqVbRqWLllXZ1OY6asGuXPneQYiMyyPbeQ-ujeCjzMFZOEVHhakCnO3nCL3cTheT-3j2dPcwuZnFlmHB40xRKRXgzBQMuJAWjGK2EILSIuNMiCy1lHKSQk6lSIBxlWWQS25tmhY5sBG63PmufbM9ptV1GSxUlXHQdEFTQhQjmFPao3yHWt-E4KHQa98_5j81wXqbmO4T038T62UX-w1dVkP-I_qOqAfUDtg0VQs-vFXdBrxegana1f_eX2Yodjk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2118310422</pqid></control><display><type>article</type><title>PET imaging in glioma: techniques and current evidence</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Mansoor, Nina M ; Thust, Stefanie ; Militano, Vincenzo ; Fraioli, Francesco</creator><creatorcontrib>Mansoor, Nina M ; Thust, Stefanie ; Militano, Vincenzo ; Fraioli, Francesco</creatorcontrib><description>PET holds potential to provide additional information about tumour metabolic processes, which could aid brain tumour differential diagnosis, grading, molecular subtyping and/or the distinction of therapy effects from disease recurrence. This review discusses PET techniques currently in use for untreated and treated glioma characterization and aims to critically assess the evidence for different tracers ([F]Fluorodeoxyglucose, choline and amino acid tracers) in this context.</description><identifier>ISSN: 0143-3636</identifier><identifier>EISSN: 1473-5628</identifier><identifier>DOI: 10.1097/MNM.0000000000000914</identifier><identifier>PMID: 30303860</identifier><language>eng</language><publisher>England: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Glioma - diagnostic imaging ; Glioma - pathology ; Glioma - therapy ; Humans ; Neoplasm Grading ; Positron-Emission Tomography - methods</subject><ispartof>Nuclear medicine communications, 2018-12, Vol.39 (12), p.1064-1080</ispartof><rights>Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3054-b82668e0baf3e456cea83cf5522fb4355b9c22419ed2657e348bbed64cc99fde3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30303860$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mansoor, Nina M</creatorcontrib><creatorcontrib>Thust, Stefanie</creatorcontrib><creatorcontrib>Militano, Vincenzo</creatorcontrib><creatorcontrib>Fraioli, Francesco</creatorcontrib><title>PET imaging in glioma: techniques and current evidence</title><title>Nuclear medicine communications</title><addtitle>Nucl Med Commun</addtitle><description>PET holds potential to provide additional information about tumour metabolic processes, which could aid brain tumour differential diagnosis, grading, molecular subtyping and/or the distinction of therapy effects from disease recurrence. This review discusses PET techniques currently in use for untreated and treated glioma characterization and aims to critically assess the evidence for different tracers ([F]Fluorodeoxyglucose, choline and amino acid tracers) in this context.</description><subject>Glioma - diagnostic imaging</subject><subject>Glioma - pathology</subject><subject>Glioma - therapy</subject><subject>Humans</subject><subject>Neoplasm Grading</subject><subject>Positron-Emission Tomography - methods</subject><issn>0143-3636</issn><issn>1473-5628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0EoqXwBwhlySbF7zjsUFUeUgssytpynEkbSJxiJ1T8PalaEGLBzGI2596ZuQidEzwmOE2u5o_zMf5dKeEHaEh4wmIhqTpEQ0w4i5lkcoBOQnjtGcVkcowGDPetJB4i-TxdRGVtlqVbRqWLllXZ1OY6asGuXPneQYiMyyPbeQ-ujeCjzMFZOEVHhakCnO3nCL3cTheT-3j2dPcwuZnFlmHB40xRKRXgzBQMuJAWjGK2EILSIuNMiCy1lHKSQk6lSIBxlWWQS25tmhY5sBG63PmufbM9ptV1GSxUlXHQdEFTQhQjmFPao3yHWt-E4KHQa98_5j81wXqbmO4T038T62UX-w1dVkP-I_qOqAfUDtg0VQs-vFXdBrxegana1f_eX2Yodjk</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Mansoor, Nina M</creator><creator>Thust, Stefanie</creator><creator>Militano, Vincenzo</creator><creator>Fraioli, Francesco</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201812</creationdate><title>PET imaging in glioma: techniques and current evidence</title><author>Mansoor, Nina M ; Thust, Stefanie ; Militano, Vincenzo ; Fraioli, Francesco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3054-b82668e0baf3e456cea83cf5522fb4355b9c22419ed2657e348bbed64cc99fde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Glioma - diagnostic imaging</topic><topic>Glioma - pathology</topic><topic>Glioma - therapy</topic><topic>Humans</topic><topic>Neoplasm Grading</topic><topic>Positron-Emission Tomography - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mansoor, Nina M</creatorcontrib><creatorcontrib>Thust, Stefanie</creatorcontrib><creatorcontrib>Militano, Vincenzo</creatorcontrib><creatorcontrib>Fraioli, Francesco</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nuclear medicine communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mansoor, Nina M</au><au>Thust, Stefanie</au><au>Militano, Vincenzo</au><au>Fraioli, Francesco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PET imaging in glioma: techniques and current evidence</atitle><jtitle>Nuclear medicine communications</jtitle><addtitle>Nucl Med Commun</addtitle><date>2018-12</date><risdate>2018</risdate><volume>39</volume><issue>12</issue><spage>1064</spage><epage>1080</epage><pages>1064-1080</pages><issn>0143-3636</issn><eissn>1473-5628</eissn><abstract>PET holds potential to provide additional information about tumour metabolic processes, which could aid brain tumour differential diagnosis, grading, molecular subtyping and/or the distinction of therapy effects from disease recurrence. This review discusses PET techniques currently in use for untreated and treated glioma characterization and aims to critically assess the evidence for different tracers ([F]Fluorodeoxyglucose, choline and amino acid tracers) in this context.</abstract><cop>England</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>30303860</pmid><doi>10.1097/MNM.0000000000000914</doi><tpages>17</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0143-3636 |
| ispartof | Nuclear medicine communications, 2018-12, Vol.39 (12), p.1064-1080 |
| issn | 0143-3636 1473-5628 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2118310422 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Glioma - diagnostic imaging Glioma - pathology Glioma - therapy Humans Neoplasm Grading Positron-Emission Tomography - methods |
| title | PET imaging in glioma: techniques and current evidence |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T06%3A57%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PET%20imaging%20in%20glioma:%20techniques%20and%20current%20evidence&rft.jtitle=Nuclear%20medicine%20communications&rft.au=Mansoor,%20Nina%20M&rft.date=2018-12&rft.volume=39&rft.issue=12&rft.spage=1064&rft.epage=1080&rft.pages=1064-1080&rft.issn=0143-3636&rft.eissn=1473-5628&rft_id=info:doi/10.1097/MNM.0000000000000914&rft_dat=%3Cproquest_cross%3E2118310422%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2118310422&rft_id=info:pmid/30303860&rfr_iscdi=true |